CIK 0001001316
- Large accelerated filer
TG THERAPEUTICS, INC.
Sign in to watch- Ticker
- TGTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 363898269
- Phone
- +1 212-554-4484
- Business address
- 2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY, 10014
- Former names
- MANHATTAN PHARMACEUTICALS INC, ATLANTIC TECHNOLOGY VENTURES INC, ATLANTIC PHARMACEUTICALS INC
- 4 Grant or award Director acquired 20,000 shares (grant or award)
- 4 Grant or award Director acquired 20,000 shares (grant or award)
- 4 Grant or award Director acquired 20,000 shares (grant or award)
- 4 Grant or award Director acquired 20,000 shares (grant or award)
- 4 Grant or award Director acquired 60,000 shares (grant or award)
- 5 Insider Annual Insider Trading Report
- 4 Grant or award CFO, Secretary and Treasurer acquired 20,000 shares (grant or award)
- 5 Insider Annual Insider Trading Report
- 4 Open-market sale Director sold 30,000 shares at $40.05 ($1,201,500)
- 4 Open-market sale 10% owner sold 158,589 shares at $25.81 ($4,092,738)
- 4 Grant or award CFO, Secretary and Treasurer acquired 250,000 shares (grant or award)
- 4 Grant or award Director acquired 65,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award CEO and President acquired 1,556,029 shares (grant or award)
- 4 Grant or award Director acquired 15,000 shares (grant or award)
- 4 Grant or award Director acquired 15,000 shares (grant or award)
- 4 Grant or award Director acquired 15,000 shares (grant or award)
- 4 Grant or award Director acquired 15,000 shares (grant or award)
- 4 Open-market sale Director sold 7,745 shares at $18.27 ($141,501)
- 3 Insider Initial Statement of Ownership
Page 4 of 18 · 353 filings